Scarica l'app Stockscreener
692.27
0.42%
-2.90
Dopo l'orario di chiusura:
692.27
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$695.17
Aprire:
$690.92
Volume 24 ore:
843.05K
Relative Volume:
0.92
Capitalizzazione di mercato:
$86.76B
Reddito:
$344.58B
Utile/perdita netta:
$2.83B
Rapporto P/E:
31.70
EPS:
21.84
Flusso di cassa netto:
$1.63B
1 W Prestazione:
-0.35%
1M Prestazione:
+4.70%
6M Prestazione:
+37.97%
1 anno Prestazione:
+30.13%
Intervallo 1D:
$670.70
$699.88
Intervallo di 1 settimana:
$670.70
$703.03
Portata 52W:
$464.42
$728.32
Mckesson Corporation Stock (MCK) Company Profile
Nome
Mckesson Corporation
Settore
Industria
Telefono
972-446-4800
Indirizzo
6555 STATE HIGHWAY 161, IRVING, TX
Confronta MCK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
692.27 | 86.76B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
284.71 | 55.10B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
134.43 | 32.56B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
65.49 | 7.75B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
6.65 | 523.01M | 10.42B | -38.77M | 323.54M | -0.51 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-04 | Ripresa | Mizuho | Neutral |
| 2024-11-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | Reiterato | Leerink Partners | Outperform |
| 2024-08-08 | Reiterato | Mizuho | Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-07-06 | Downgrade | Argus | Buy → Hold |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-02-04 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | Reiterato | Barclays | Overweight |
| 2021-11-02 | Reiterato | BofA Securities | Buy |
| 2021-11-02 | Reiterato | Evercore ISI | Outperform |
| 2021-11-02 | Reiterato | Jefferies | Buy |
| 2021-03-30 | Aggiornamento | Argus | Hold → Buy |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-08-04 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-05-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-18 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-13 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-05 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-10-26 | Reiterato | Barclays | Equal Weight |
| 2018-07-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-02 | Reiterato | Mizuho | Neutral |
| 2018-01-24 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Mckesson Corporation Borsa (MCK) Ultime notizie
Jim Cramer Reaffirms McKesson (MCK): “One of the Strongest Stocks in the Market” - MSN
McKesson Launches Initiative to Advance Precision Medicine in Community Oncology - Dallas Innovates
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo
Lobbying Update: $1,220,000 of MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS lobbying was just disclosed - Nasdaq
McKesson Corporation (MCK): One of the Dividend Stocks with Sustainable Payout Ratios - MSN
McKesson Careers | The future of health starts with you. - McKesson Careers
Jim Cramer Labels McKesson Corporation (MCK) a “Money Machine – A Must-Own Middleman” - Insider Monkey
McKesson Launches Precision Care Companion for Biomarker-Driven Cancer Care - HIT Consultant
McKesson is medicine for Elite Investors in market chaos - Citywire
Jim Cramer’s List of 16 Stocks to Buy Right Now - Insider Monkey
Citigroup Adjusts Price Target on McKesson to $800 From $685, Maintains Buy Rating - marketscreener.com
McKesson provides Elite Investors with medicine for market choas - Citywire
McKesson (MCK) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
McKesson Launches Collaboration to Boost Precision Oncology Adoption - Inside Precision Medicine
McKesson (NYSE:MCK) Launches Precision Care Initiative Transforming Oncology Treatment - Yahoo Finance
Jim Cramer: McKesson (MCK) Is a “Money Machine” – Funds Keep Flowing In - Insider Monkey
McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology - Business Wire
McKesson Corporation (MCK): Among the Best Value Dividend Stocks to Buy According to Billionaires - Yahoo Finance
3 Dividend Stocks Built for Stability as Growth Trades Cool Off - Investing.com
Middlemen Always Work.” – Jim Cramer’s Love for McKesson Corporation (MCK) - Insider Monkey
GS1 US to host webinar on McKesson, Target supply chain traceability - Supermarket Perimeter
GS1 to host webinar on McKesson, Target supply chain traceability - Supermarket Perimeter
McKesson (MCK) Sees Price Target Boost to $755 by BofA | CAH Sto - GuruFocus
McKesson To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
McKesson and Wegmans: A Long-Standing Partnership in Advancing Pharmacy - NEWS CHANNEL NEBRASKA
Why the Market Dipped But McKesson (MCK) Gained Today - Yahoo Finance
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know - MSN
Jonathan Jackson from Illinois’s 1st district makes notable trades in Microsoft, Salesforce, and McKesson - Investing.com India
This Medical Supplies Distributor Dodges A Tariff Bullet - Investor's Business Daily
Evercore ISI Adjusts Price Target on McKesson to $740 From $675, Maintains Outperform Rating - MarketScreener
McKesson (MCK) Stock Moves -1.38%: What You Should Know - Yahoo Finance
McKesson opens registration for 2025 ideaShare conference - Drug Store News
Registration Opens for Annual McKesson ideaShare Conference - Yahoo Finance
Quad-C Management Completes the Sale of PRISM Vision to McKesson - PR Newswire
Quad-C sells stake in Prism Vision to McKesson Corporation - pehub.com
McKesson Corporation (MCK): Jim Cramer’s Top Pick – Why He Thinks McKesson Can ‘Jack Prices Up’ - Insider Monkey
Zacks Research Brokers Lift Earnings Estimates for McKesson - Defense World
Rite Aid weighs repeat bankruptcy filing, WSJ reports - MarketScreener
McKesson In Huge Group New To IBD 50: Check Out Which Stocks Just Came On – And Off – IBD's Top Stock Screens - Investor's Business Daily
McKesson stock soars to all-time high of $726.13 By Investing.com - Investing.com South Africa
McKesson stock soars to all-time high of $726.13 - Investing.com
Mizuho raises McKesson stock target to $690, maintains neutral By Investing.com - Investing.com South Africa
MCK Stock Gains as PRISM Acquisition Adds High-Growth Business - TradingView
McKesson Corporation completed the acquisition of 80% stake in PRISM Vision Group from Quad-C Management, Inc. - MarketScreener
Deutsche Bank Adjusts Price Target on McKesson to $692 From $700, Maintains Buy Rating - MarketScreener
Mizuho Adjusts Price Target on McKesson to $690 From $630, Maintains Neutral Rating - MarketScreener
McKesson price target raised to $690 from $630 at Mizuho - TipRanks
Mckesson Corporation Azioni (MCK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.54%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):